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Detection and characteristics of microvascular
obstruction in reperfused acute myocardial
infarction using an optimized protocol
for contrast-enhanced cardiovascular magnetic
resonance imaging
Abstract Several cardiovascular
magnetic resonance imaging (CMR)
techniques are used to detect
microvascular obstruction (MVO)
after acute myocardial infarction
(AMI). To determine the prevalence of
MVO and gain more insight into the
dynamic changes in appearance of
MVO, we studied 84 consecutive
patients with a reperfused AMI on
average 5 and 104 days after
admission, using an optimised single
breath-hold 3D inversion recovery
gradient echo pulse sequence
(IR-GRE) protocol. Early MVO
(2 min post-contrast) was detected in
53 patients (63%) and late MVO
(10 min post-contrast) in 45 patients
(54%; p=0.008). The extent of MVO
decreased from early to late imaging
(4.3±3.2% vs. 1.8±1.8%, p<0.001)
and showed a heterogeneous pattern.
At baseline, patients without MVO
(early and late) had a higher left
ventricular ejection fraction (LVEF)
than patients with persistent late MVO
(56±7% vs. 48±7%, p<0.001) and
LVEF was intermediate in patients
with early MVO but late MVO
disappearance (54±6%). During
follow-up, LVEF improved in all three
subgroupsbutremainedintermediatein
patients with late MVO disappearance.
This optimised single breath-hold 3D
IR-GRE technique for imaging MVO
early and late after contrast adminis-
tration is fast, accurate and allows
detection of patients with intermediate
remodelling at follow-up.
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Introduction
Reperfusion therapy in patients with acute myocardial
infarction (AMI) salvages myocardium and reduces mor-
tality [1–3]. However, successful restoration of epicardial
coronary artery patency after prolonged occlusion does not
always lead to adequate reperfusion at the microvascular
level. Previous studies have shown that the presence and
absolute amount of microvascular obstruction (MVO) are
associated with adverse left ventricular remodelling and
prognosis [4–7]. Microvascular flow after reperfusion is
spatially and temporally complex, with coexisting regions
of hyperaemia, impaired vasodilatory flow reserve, low
flow and no reflow. The magnitude and spatial extent of
these perfusion patterns vary over time [8].
MVO can be detected with cardiovascular magnetic
resonance imaging (CMR) using the technique of first pass
perfusion imaging (FP) and traditional late contrast-
enhanced CMR (late CE-CMR), but no consensus exists
on which technique is more accurate [5, 9–11]. Theimportance of detecting MVO early after contrast injection
is increasingly being recognised and has led to the
development of additional CMR techniques [12, 13].
Whereas traditional late CE-CMR may underestimate the
true extent of MVO as a result of diffusion of gadolinium
into the area of MVO over time, FP allows only incomplete
coverage of the left ventricle and has a lower signal-to-
noise ratio and spatial resolution. When the technique of
traditional late CE-CMR is performed early after contrast
administration (early CE-CMR), the advantages of com-
plete ventricular coverage, optimal signal-to-noise (SNR)
and spatial resolution are combined and may overcome
these shortcomings.
Optimal timing of imaging MVO and the dynamic
changes of MVO over time in relation to clinical variables
are not well known. In this study, a 3D inversion recovery
pulse sequence was used early and late after contrast
administration to determine the prevalence of MVO and
gain more insight into the dynamic changes in appearance
of MVO in relation to clinical variables. For early imaging
the inversion time of the imaging sequence was first
optimised in a pilot study.
Materials and methods
Patients
The study was approved by the institutional review
board of our hospital, and patients were included after
written informed consent was obtained. Between
August 2006 and March 2008, 84 consecutive patients
with a first ST segment elevation myocardial infarction
(STEMI) referred to our institution for primary percu-
taneous coronary intervention (PCI) and presentation
less than 12 h after symptom onset were prospectively
studied. Definition of myocardial infarction (MI) was
based on the recent consensus document including
appropriate rise and fall in cardiac biomarkers [14].
Excluded were patients with claustrophobia, contra-
indications for CMR (cerebral clips, pacemakers,
defibrillators, neurostimulators), severe congestive
heart failure or cardiogenic shock (Killip class III and
IV) at the time of CMR, atrial fibrillation, age below
18 years, severe renal failure (stage 4 or 5) and
pregnancy.
Before emergency PCI all patients received aspirin
(500 mg), heparin (5,000 U) and clopidogrel (600 mg). Use
of thrombosuction and downstream administration of
intravenous antiplatelet agents (abciximab), intracoronary
nitroglycerine and adenosine were left to the discretion of
the interventional cardiologist.
Cardiac biomarkers were sampled on admission, and at
6-, 12-, 18-, 24-, 36-, 48- and 72-h intervals. Area under the
curve (AUC) biomarker levels were derived and expressed
as 1,000 h units l
−1.
CMR protocol
Patients underwent CMR imaging 5±2 days (range 2–
10 days) and 104±11 days (range 88–122 days) after
admission. Images were acquired during multiple breath-
holds on a 1.5-T MRI system (Philips Intera, Philips
Medical Systems, Best, the Netherlands) with a cardiac
software package and dedicated five-element phased array
surface coil. ECG-gated cine images were obtained for
functional analysis using a steady-state free precession
sequence (slice thickness 6 mm, slice gap 4 mm, average
repetition time (TR) and echo time (TE) 3.8/1.9 ms,
respectively, flip angle 50°, FOV 350 mm, matrix 256×
256, typically 22–25 phases per cardiac cycle), in the
following orientations: single slice two-chamber long axis,
three-chamber long axis, four-chamber long axis, and a
short axis stack covering the left ventricle (LV) from the
base to apex (typically 10–14 slices).
Subsequently, a single breath-hold (15–20 s) 3D inversion
recovery gradient echo sequence completely covering the LV
wasusedforearlyandlateCE-CMR(acquiredslicethickness
12 mm, reconstructed slice thickness 6 mm, average TR/TE
3.9/2.4 ms, multishot (50 profiles/shot) segmented partial
echo readout every heartbeat (TFE), flip angle 15°, FOV
400 mm, matrix 256×256, acquired and reconstructed pixel
size 1.56×1.56 mm, typically 16–18 slices). The pulse
sequence was run at 2 and 10 min after intravenous
administration of 0.2 mmol/kg body weight gadolinium
diethylenetriaminepentaacetic acid (Gd-DTPA, Magnevist®,
Schering, Germany; injection rate 3 ml/s). For early CE-
CMR, the inversion time was first optimised in a pilot study:
Pilot study to find optimal TI for early CE-CMR
We set out to find an optimal inversion time (TI) for
early CE-CMR. For this, Look–Locker images acquired
2 min after intravenous administration of gadolinium
(0.2 mmol/kg body weight; injection rate 3 ml/s) were
quantitatively analysed in eight separate patients. This
Look–Locker gradient echo (GRE) pulse sequence
(slice thickness 10 mm, average TR/TE 3.6/1.7 ms,
multishot (3 profiles/shot) segmented full echo readout
every heartbeat, flip angle 8°, FOV 370 mm, resolution
256×256, 39 phases, phase interval 15 ms) was applied
at the short axis level with the most pronounced wall
motion abnormalities. For analysis, epicardial and
endocardial contours were manually drawn in each
phase. Additional regions of interest (ROIs) were
defined in: (1) a subendocardial hypoenhanced region
(MVO), (2) a region adjacent to the hypoenhanced
region (infarcted myocardium) and (3) noninfarcted
(normal) myocardium (Fig. 1). All contours and ROIs
were carefully adjusted for cardiac motion as a result
of contraction and breathing. The signal intensities (SI)
of MVO, infarcted and noninfarcted myocardium were
2905determined as a function of the Look–Locker TI
(Fig. 2a). Measured inversion recovery SI curves were
mathematically fitted to the inversion recovery magnetisa-
tion function, which provides estimates of the T1 relax-
ation time of these tissue regions [15]. T1 parameter
estimations were calculated in the MATLAB (The Math-
Works, Natick, MA) programming environment using a
Levenberg–Marquardt nonlinear fitting algorithm. As the
implemented Look–Locker pulse sequences provided
magnitude images, the Rician noise distribution was
taken into account [16]. Subsequently, the fitted SI curves
ofMVOandinfarctedmyocardiumweresubtractedtofind
theTIofmaximumcontrast,wherecontrastwasdefinedas
the difference in signal intensity (SI) between MVO and
adjacent infarcted myocardium:
ΔSI TI ðÞ ¼ SIinfarct TI ðÞ   SIMVO TI ðÞ :
The TI for which this contrast between MVO and adjacent
infarcted myocardium was maximal would at first sight
provide the optimal TI for early CE-CMR (Fig. 2a).
However, a broad range of TI values (approximately 300–
700 ms) were found with suboptimal overall signal
characteristics of normal and infarcted myocardium. It was
beneficial to use higher TI values, because higher signal
levels will be acquired at nearly constant contrast, but with
improved endocardial and epicardial border definition. This
observationledustodefineameritfunction(MF),whichwas
defined asthe product of the signaldifferencebetweenMVO
andinfarctedmyocardiummultipliedbythesignalintensityof
noninfarcted myocardium (SInormal)( F i g .2b):
MF TI ðÞ ¼ SIinfarct TI ðÞ   SIMVO TI ðÞ ½    SInormal
Withthisapproach,bothcontrastandsignalcharacteristics
were simultaneously optimised. The merit function had a
more narrow range of optimal TI values. The TI value of
530ms(528±201ms),forwhichthismeritfunctionhasits
maximum, was used for subsequent early CE-CMR.
Early CE-CMR
With the inversion time (TI) set to 530 ms, images showed
increased signal intensity of the blood pool in the
ventricular lumen, infarcted and noninfarcted myocardium.
MVO was defined as a central hypoenhanced region within
the area of the infarct-related artery (Fig. 3, left panel).
Standard late CE-CMR
Based on the results of a Look–Locker sequence run at
10 min after contrast injection (8 min after early CE-CMR),
images were then acquired with an individually set
inversion time (typical range 200–280 ms) to optimally
“null” noninfarcted myocardium. MVO was defined as a
persistent central hypoenhanced area within the hyper-
enhanced area (Fig. 3, right panel).
CMR image analysis
CMR images were analysed off-line using commercially
available software (CAAS MRV 3.0, Pie Medical Imaging,
Maastricht, the Netherlands) blinded to clinical informa-
tion. Endocardial and epicardial contours were manually
traced in end-diastolic and end-systolic short axis slices to
determine left ventricular end-diastolic volume (LVEDV)
Fig. 1 Look–Locker images (left panel) in a patient with regions of
interest (ROIs) drawn in only one phase (right panel, enlarged from
left panel). Left panel 39 phases of a single slice Look–Locker
sequence in one of the eight patients. Right panel phase 20 is
enlarged to demonstrate the different ROIs that were drawn in all
phases: subendocardial hypoenhanced region (MVO) (dotted line),
region directly adjacent to the hypoenhanced region (infarcted
myocardium) (solid black line), region of noninfarcted (normal)
myocardium (dotted-dashed line)
2906and left ventricular end-systolic volume (LVESV), left
ventricular ejection fraction (LVEF), and left ventricular
end-diastolic mass and were indexed to body surface area
(BSA). Endocardial and epicardial contours were manually
traced on both early and late CE-CMR images. The
presence or absence of MVO was determined indepen-
dently by two experienced observers. Infarct size was
measured on the late CE-CMR images by manual
planimetry of hyperenhanced areas (including central
hypoenhancement if present) and expressed as a percentage
of LV mass.
Statistical analysis
Continuous data are expressed as mean ± SD or as median
and range when non-normally distributed. Categorical data
are expressed as frequencies with percentages. Differences
between patients with and without early MVO were tested
using an unpaired t test. Spearman’s rank correlation
coefficient (r) was used to determine correlations. The
differences between proportions of paired categorical data
were analysed using McNemar’s test. All images were
independently analysed by two observers blinded to the
clinical data to determine the presence or absence of MVO,
both for early and late. The interobserver agreement
between readers was analysed by using kappa (κ) statistics.
The same statistics was used to check agreement between
early and late MVOby oneobserver only. Unless otherwise
stated, a two-tailed p value less than 0.05 was considered
statistically significant.
Depending on the MVO status, patients were classified
into three groups: those without MVO on early and late
CE-CMR (absence), those with MVO on both early and
late CE-CMR (persistence), and those with MVO on early
but not late CE-CMR (disappearance). Comparisons
among these groups were conducted either with the
parametric one-way ANOVA or the nonparametric Krus-
kal–Wallis test for continuous variables. Post hoc pairwise
comparisons were Bonferroni corrected. For categorical
variables Chi-squared or Fisher’s exact tests were applied.
Logistic univariable regression models were fitted to
investigate which variables individually were significantly
associated with presence of MVO (persistence or disap-
pearance). Subsequently, only significant predictors (at a
0.1 significance level) were added to a multivariate model
to estimate their independent/adjusted effects. Similarly,
univariable logistic regression followed by multivariable
analyses were conducted to detect independent predictors
of MVO disappearance.
A paired sample t test was used to investigate whether
LVEDV index and LVEF significantly changed between
baseline and follow-up measurements. Statistical analysis
was performed with SPSS software (version 15.0 for
Windows; SPSS Inc., Chicago, Illinois).
Results
The mean patient age was 60±11 years and 61 (73%) were
men (Table 1). Most myocardial infarctions involved the
right coronary artery (55%), followed by the left anterior
descending (32%) and circumflex artery (13%). More than
half of the patients had single vessel disease (52%). PCI
with stenting was performed in 80 patients (95%). In four
Fig. 2 Signal intensity curves obtained from the Look–Locker
sequence (a) and merit function of contrast and SNR. The MR-
derived quantity was normalized to the maximum value (b). a Signal
intensity (SI) curves in the region of microvascular obstruction
(MVO), infarcted and noninfarcted myocardium obtained from
Look–Locker inversion recovery images in a representative patient.
Maximum contrast (i.e. SI difference) between MVO and infarcted
myocardium would be obtained at an inversion time of approxi-
mately 340 ms. b Combining optimised contrast and overall signal,
the merit function provides a much less broader optimum at an
inversion time of 465 ms for this case than for the contrast between
MVO and infarcted area. Note the broad maximum in b and the
relatively low signal at 340 ms (i.e. maximal SI difference in this
case) in a
2907patients no PCI was performed because of baseline
thrombolysis in myocardial infarction (TIMI) 3 flow and a
residual stenosis less than 30%. Thrombosuction was
performedin26patients(31%),andintracoronaryadenosine
or nitroglycerine was given in 57 patients (68%). Down-
streamabciximabwasgivenin43patients(51%).FinalTIMI
3flowwas establishedin75patients(89%)andTIMI 2flow
in the remaining 9 patients (11%). The mean time from
symptom onset to first balloon inflation or stent placement
(totalischaemictime)was219±85min.MeanCKareaunder
thecurve(AUC)was54±37(1,000hunitsl
−1).Meaninfarct
size was 16±11% of the LV mass.
Early CE-CMR
MVO on early CE-CMR was observed in 53 patients
(63%). The extent of MVO was 4.3±3.2% of the LV mass;
expressed as absolute values this was 7.8±6.4 g. Com-
pared with patients with absence of MVO, those with
MVO had a higher left ventricular end-systolic volume
index (LVESVi) (45±13 ml/m
2 vs. 37±11 ml/m
2,
p=0.008), lower ejection fraction (49±7% vs. 56±7%,
p<0.001), larger infarct size (21±9% vs. 6±8%, p<0.001)
and higher CK AUC (68±32 vs. 30±31 (1,000 h units l
−1),
p<0.001). Left ventricular end-diastolic volume index
(LVEDVi) and LV mass tended to be higher in patients
with MVO but did not reach statistical significance (86±
17ml/m
2vs.81±14ml/m
2,p=0.2and64±12g/m
2vs.59±
10 g/m
2, p=0.07, respectively).
In the multivariable analysis with variables from Table 1,
only infarct size remained an independent predictor of the
presence of MVO (expβ (OR) 1.2, 95%CI 1.1–1.3,
p<0.0001).
Fig. 3 Early (left panel) and late CE-CMR images (right panel)i n
one of the patients. Two sets of four contiguous short axis slices at
midlevel of the LV in a patient 5 days after reperfused acute
anteroseptal wall myocardial infarction. Left panel 2 min after
contrast injection: the blood pool (*) and myocardium show
increased signal intensity (arrow), except for a central dark
anteroseptal rim (arrowhead; early MVO). Right panel late hyper-
and hypoenhancement: 10 min after contrast injection, signal from
noninfarcted myocardium is “nulled” (black arrow) and the
infarcted myocardium is hyperenhanced (white arrow). A dark
central rim is observed within the bright area (late MVO;
arrowhead)
Table 1 Patient characteristics
Characteristic Value
Age (years) 60±11
Male sex 61 (73)
BMI 27±4
Smoking 74 (88)
Hypercholesterolaemia 30 (36)
Diabetes 5 (6)
Previous angina pectoris 38 (45)
Culprit
RCA 46 (55)
LAD 27 (32)
Cx 11 (13)
Number of diseased vessels
a
One 44 (52)
Two 19 (23)
Three 21 (25)
Thrombosuction 26 (31)
Time to balloon inflation (min) 219±85
Adenosine or nitroglycerine i.c. 57 (68)
Abciximab downstream 43 (51)
Final TIMI 3 flow 75 (89)
CK (AUC, 1,000 h units l
−1)5 4 ± 3 7
Infarct size (% of LV mass) 16±11
Values are presented as number of patients with percentages in
parentheses or mean ± standard deviation
Abbreviations: i.c. intracoronary, AUC area under the curve, BMI
body mass index, RCA right coronary artery, LAD left anterior
descending artery, Cx circumflex artery
aStenosis greater than 70%
2908Late CE-CMR
MVO on late CE-CMR (persistence of MVO) was
observed in 45 patients (54%) compared with 53 (63%)
patients with MVO on early CE-CMR (p=0.008). Late
MVO disappeared in eight patients (9%) at the later time
point. Late MVO was always found at the same location as
early MVO (Fig. 3). The agreement between early and late
MVO (κ=0.8, p<0.001, Table 2) and the correlation
between the extent of early and late MVO were good (r=
0.8, p<0.0001, Fig. 4). The interobserver agreement for the
presence or absence of early and late MVO was excellent (k
value 0.9 for both early and late measurements, p<0.001).
Early vs. late CE-CMR
In all except one patient, the extent of MVO decreased
significantly fromearly to late imaging(4.3±3.2%vs. 1.8±
1.8%,p<0.001,Figs.3and5).Themedian decrementinall
patients was 66% (range 0–100%); expressed as absolute
amounts this resulted in a median decrement of 3.4 g (range
0–21g).Theindividualdecrementwasquiteheterogeneous
(Fig. 5).
Thus, early MVO was absent in 31 (37%) patients,
persisted in 45 (54%) patients and disappeared in 8 (9%)
patients during late CE-CMR. Most baseline characteristics
were not found to be related to absence, persistence and
disappearance of MVO (Table 3). At baseline, infarct size
and CK AUC were smallest and lowest in patients with
absence of MVO, and largest for patients with persistence
of late MVO (30±31 vs. 73±32 (1,000 h units l
−1) and 6±
8% vs. 23±9%, p<0.001 for both). In addition, LVEF was
highest in patients with absence of MVO, and lowest for
patients with persistence of MVO (56±7 vs. 48±7%,
p<0.001).
The eight patients with disappearance of MVO had an
infarct size and LVEF that was intermediate between those
of patients with absence and persistence of MVO (12±4%
and 54±6%, respectively, Table 3). These eight patients
had a significantly smaller extent of early MVO than
patients with persistent late MVO (0.8±0.4% vs. 5±3.1%,
p<0.001, Fig. 5).
None of the clinical variables from Table 2 was found to
be a significant predictor of MVO disappearance. From the
CMR variables and after correction, only a smaller extent
of early MVO remained independently associated with
disappearance of late MVO (expβ (OR) 0.034, 95%CI
0.001–0.908, p<0.04).
Follow-up CMR
LVEDV index decreased and LVEF increased in all three
subgroups as compared with baseline (Table 3). LVEF
remained highest in patients without MVO as compared
with patients with persistence of late MVO (59± 6% vs.
51±7%, p<0.001). LVEF in patients with late MVO
disappearance remained intermediate (55±4%).
Discussion
The findings of this study in 84 patients with a reperfused
first acute STEMI can be summarised as follows. First, the
prevalence of MVO early after contrast injection at 2 min
(earlyMVO)ishigherthanwithtraditionallateCE-CMRat
10 min (late MVO) using an optimised single breath-hold
3Dinversionrecoverygradientechotechnique.Second,the
extent of MVO decreases significantly depending on the
time of imaging after contrast administration and this
decrease is quite heterogeneous (Figs. 3 and 5). Only the
Fig. 4 Correlation between early and late MVO. A good correlation
was found between the extent of early and persistent late MVO. The
average extent of early MVO was larger than that of persistent late
MVO (r=0.78, p<0.001). The dotted line represents the line of
identity and emphasises the inequality of the measures
Table 2 Agreement between early and late MVO
Early MVO Late MVO
Yes (%) No (%) Total (%)
Yes (%) 45 (54) 8 53 (63)
No (%) 0 31 (37) 31 (37)
Total (%) 45 (54) 39 (46) 84 (100)
Values are presented as number of patients with percentages in
parentheses
Good agreement was found between early and late MVO (κ=0.8,
p<0.001)
2909extent of early MVO is independently associated with
persistence of late MVO. At baseline, patients with absence
of MVO (early and late) have a significantly smaller infarct
size and higher LVEF than patients with persistence of late
MVO.InpatientswithearlybutlatedisappearanceofMVO
(n=8), infarct size and LVEF are intermediate between
those with absence and persistence of MVO and LVEF
remains intermediate at follow-up.
TheprevalenceofMVOnotonlydependsonthetimingof
imaging after infarction but also on the timing of imaging
after contrast administration [9, 17]. In addition, it depends
on the imaging technique used and as a consequence the
reported prevalence of MVO has been inconsistent, ranging
between 38 and 84% using FP and between 28 and 36%
usingtraditionallateenhancementimaging[9,18].Although
the numbers were not greatly different, we found that the
prevalence of MVO using early CE-CMR at 2 min after
contrast administration was significantly higher compared
with late CE-CMR. Early MVO completely filled in during
late CE-CMR in 10% of patients.
Despite the importance of detecting MVO in AMI
patients, a ‘gold standard’ for the clinical detection of
MVO has not been established yet. Several techniques
measuring slightly different biological parameters are
currently used (TIMI flow, blush grade, ST segment
resolution, myocardial contrast echocardiography and scin-
tigraphy). In addition, different CMR techniques are being
used such as traditional late CE-CMR, contrast-enhanced
cine MR imaging, T2-weighted imaging and FP, but the
sensitivity is still undetermined [5, 9–11, 17, 19–22].
For the detection of early MVO, FP seems sensitive
because of its histopathological correlation to MVO, as
measured with thioflavin S staining and radioactive
microsphere blood flow measurements in experimental
studies [23]. FP, however, is hampered by incomplete left
ventricular coverage, low SNR and low spatial resolution.
Because of these shortcomings, other fast CMR techniques
are increasingly being used for the detection of MVO early
after contrast administration, including 3D T1-weighted
inversion recovery gradient echo techniques [13, 24].
However, these studies did not specify the inversion times
that were used for early imaging. Because we first optimised
the inversion time for early imaging our approach allows
imaging of the complete LV within a single breath-hold with
good resolution, signal and contrast to noise.
As we used the same pulse sequence for early and late
CE-CMR, except for different inversion times, this enabled
us to accurately evaluate the dynamic changes in appear-
ance of MVO over time. In all but one patient the extent of
MVO significantly decreased from early to late imaging.
We found a great heterogeneity in the shrinkage of MVO
over time, indicating that the prevalence of MVO is only
one part of the larger underlying pathophysiology of MVO
(Figs. 3 and 5). For the first time we have described this
heterogeneity in the shrinkage of MVO by using CMR. It
likely represents the underlying heterogeneity in tissue
perfusion, which was previously demonstrated in experi-
mental studies. Negligible flow within the infarct core and
progressively increasing flow towards the outer edges of
the infarcted region are likely related to varying degrees of
microvascular damage and obstruction [23, 25, 26].
Whether this relates to varying degrees of remodelling
over time or carries adverse prognostic information is
currently unknown and needs to be studied further.
Our protocol enabled us to distinguish an additional
group of patients with early but disappearance of late
MVO. Recently, Nijveldt et al. compared three CMR
techniques (early, intermediate and late hypoenhancement
imaging) but did not specifically describe this subgroup
[13]. They found intermediate hypoenhancement in only
two additional patients (3%) compared with late hypoen-
hancement, whereas we observed this in eight additional
patients (10%). Although late hypoenhancement was the
strongest predictor of LV remodelling over time in their
study, we have shown that these patients have an LVEF that
is intermediate at baseline and after follow-up. This may
imply that these patients represent an intermediate risk
group and should not be excluded from future therapies for
MVO.
Fig. 5 Change in the extent of MVO. In all patients, the extent of
early MVO decreased significantly but showed a heterogeneous
pattern (MVO persistence (x····x)). In eight patients early MVO
disappeared during late CE-CMR (•⎯•). These patients had a
significantly smaller extent of early MVO than the patients with
persistence of MVO (0.8%±0.4% vs. 5±3.1%, p<0.001)
2910There are some limitations to our study. The inversion
times used for the 3D inversion recovery sequence of both
early and late CE-CMR were determined with a Look–
Locker sequence. Although both sequences are gradient
echo (GRE) readouts, the inherent difference in sequence
parameters may cause differences in the amount of T1
weighting. It is therefore possible that the inversion times
determined in our study are close but may be slightly out of
kilter with the optimal inversion times for early and late
CE-CMR. As the TI used in early CE-CMR was far above
the “null” point for normal myocardium, small uncertain-
ties in the optimal TI for early CE-CMR are not that critical
as those for late CE-CMR. The optimal TI for late CE-
CMR is traditionally set to “null” healthy myocardium 10–
15 min after contrast administration in each patient. This is
not possible for early CE-CMR, as the 2-min interval is too
short for individual patients. Therefore, optimal TI for early
CE-CMR was first determined in a pilot study.
The 2-min interval was chosen in line with histopath-
ological validation of MVO in earlier studies [17, 23]. With
even earlier imaging (i.e. 30 s) sensitivity may increase but
specificity may be decreased, because central hypoen-
hancement may appear in the setting of significant
epicardial coronary disease even in the absence of myo-
cardial infarction. Moreover, in our study we were
interested in the dynamic change in appearance of MVO
over time. Earlier imaging might have possibly shown a
greater level of dynamic change. However, because most
patients showed substantial shrinkage of MVO, the exact
timing of early imaging is not expected to be that critical.
Table 3 Patient characteristics in relation to MVO category (absence, disappearance and persistence)
Early MVO
Absent Present
Disappearance late MVO (−) Persistence late MVO (+)
(n=31) (n=8) (n=45) p value
Age (years) 61±9 61±10 59±13 0.8
Male sex 22 (71) 5 (63) 34 (76) 0.7
BMI 27±4 26±2 27±4 0.7
Smoking 26 (84) 7 (88) 41 (91) 0.6
Hypercholesterolaemia 8 (35) 2 (29) 13 (37) 0.9
Diabetes 3 (10) 0 2 (4) 0.4
Previous angina pectoris 11 (36) 2 (25) 20 (44) 0.5
Anterior localisation of MI 7 (23) 1 (13) 19 (42) 0.08
Three-vessel disease* 8 (26) 1 (13) 12 (27) 0.7
Thrombosuction 9 (29) 2 (25) 15 (33) 0.9
Time to balloon inflation (min) 232±96 196±80 215±80 0.6
Adenosine or nitroglycerine i.c. 21 (68) 5 (63) 31 (69) 0.9
Abciximab downstream 12 (39) 5 (63) 26 (58) 0.2
Final TIMI 3 flow 27 (90) 5 (71) 41 (91) 0.3
Total CK (AUC, 1,000 h units l
−1)3 0 ± 3 1
a 39±14
b 73±32
a, b <0.001
a/0.01
b
Baseline CMR
LVEDVi (ml/m
2) 81±14 87±17 86±17 0.4
LVEF (%) 56±7
c 54±6 48±7
c <0.001
c
Infarct size (% LV) 6±8
d 12±4
e 23±9
d,e <0.001
d/0.003
e
Early MVO size (% of LV) 0
f 0.8±0.4 5±3.1
f <0.001
f
Follow-up CMR
LVEDVi (ml/m
2) 76±17 85±16 84±20 0.2
LVEF (%) 59±6
g 55±4 51±7
g <0.001
g
Values are presented as number of patients with percentages in parentheses or mean ± standard deviation
Abbreviations: BMI body mass index, i.c. intracoronary, AUC area under the curve, LVEDVi left ventricular end-diastolic volume index,
LVESVi left ventricular end-systolic volume index, LVSVi left ventricular stroke volume index, LVEF left ventricular ejection fraction, LVMi
left ventricular mass index, LE late enhancement, MVO microvascular obstruction
*Stenosis greater than 70%
a,c,d,f,gFor the difference between absence of MVO (early and late) and persistence of late MVO
b,eFor the difference between disappearance and persistence of late MVO
2911In conclusion, using an optimised single breath-hold 3D
inversion recovery gradient echo pulse sequence, the
prevalence of MVO early after the injection of contrast
medium is higher than with traditional late CE-CMR. Our
results show that the appearance of MVO is dynamic and
heterogeneous, and imaging MVO early and late after
contrast administration may give more information about
the severity and pathophysiology of MVO. In addition, this
approach allows the discrimination of MVO subgroups that
have different infarct sizes and remodelling parameters.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which
permits any noncommercial use, distribution, and reproduction in
any medium, provided the original author(s) and source are credited.
References
1. The GUSTO investigators (1993) An
international randomized trial compar-
ing four thrombolytic strategies for
acute myocardial infarction. N Engl J
Med 329:673–682
2. Serruys PW, Simoons ML,
Suryapranata H et al (1986) Preserva-
tion of global and regional left ven-
tricular function after early thromboly-
sis in acute myocardial infarction. J Am
Coll Cardiol 7:729–742
3. Sheehan FH, Doerr R, Schmidt WG et
al (1988) Early recovery of left ven-
tricular function after thrombolytic
therapy for acute myocardial infarction:
an important determinant of survival. J
Am Coll Cardiol 12:289–300
4. Gerber BL, Rochitte CE, Melin JA et al
(2000) Microvascular obstruction and
left ventricular remodeling early after
acute myocardial infarction. Circulation
101:2734–2741
5. Hombach V, Grebe O, Merkle N et al
(2005) Sequelae of acute myocardial
infarction regarding cardiac structure
and function and their prognostic
significance as assessed by magnetic
resonance imaging. Eur Heart J
26:549–557
6. Ito H, Tomooka T, Sakai N et al (1992)
Lack of myocardial perfusion immedi-
ately after successful thrombolysis. A
predictor of poor recovery of left ven-
tricular function in anterior myocardial
infarction. Circulation 85:1699–1705
7. Wu KC, Zerhouni EA, Judd RM et al
(1998) Prognostic significance of mi-
crovascular obstruction by magnetic
resonance imaging in patients with
acute myocardial infarction. Circulation
97:765–772
8. Villanueva FS (2002) Myocardial con-
trast echocardiography in acute myo-
cardial infarction. Am J Cardiol
90:38J–47J
9. Lund GK, Stork A, Saeed M et al
(2004) Acute myocardial infarction:
evaluation with first-pass enhancement
and delayed enhancement MR imaging
compared with
201Tl SPECT imaging.
Radiology 232:49–57
10. Taylor AJ, Al-Saadi N, Abdel-Aty H,
Schulz-Menger J, Messroghli DR,
Friedrich MG (2004) Detection of
acutely impaired microvascular reper-
fusion after infarct angioplasty with
magnetic resonance imaging. Circula-
tion 109:2080–2085
11. Tarantini G, Cacciavillani L, Corbetti F
et al (2005) Duration of ischemia is a
major determinant of transmurality and
severe microvascular obstruction after
primary angioplasty: a study performed
with contrast-enhanced magnetic reso-
nance.JAmCollCardiol46:1229–1235
12. Comte A, Kastler B, Laborie L,
Hadjidekov G, Meneveau N,
Boulahdour H (2008) Using a contrast-
enhanced imaging sequence at
3-minute delay in 3-T magnetic reso-
nance imaging for acute infarct eva-
luation. Invest Radiol 43:669–675
13. Nijveldt R, Hofman MB, Hirsch A et al
(2009) Assessment of microvascular
obstruction and prediction of short-term
remodeling after acute myocardial in-
farction: cardiac MR imaging study.
Radiology 250:363–370
14. Thygesen K, Alpert JS, White HD et al
(2007) Universal definition of myocar-
dial infarction. Circulation 116:2634–
2653
15. Haacke EMBR, Thompson MR (1999)
Magnetic resonance imaging, physical
principles and sequence design. Wiley,
New York, pp 133–134
16. Karlsen OT, Verhagen R, Bovee WM
(1999) Parameter estimation from
Rician-distributed data sets using a
maximum likelihood estimator: appli-
cation to T1 and perfusion measure-
ments. Magn Reson Med 41:614–623
17. Rochitte CE, Lima JA, Bluemke DA et
al (1998) Magnitude and time course of
microvascular obstruction and tissue
injury after acute myocardial infarction.
Circulation 98:1006–1014
18. Yan AT, Gibson CM, Larose E et al
(2006) Characterization of microvas-
cular dysfunction after acute
myocardial infarction by cardiovascular
magnetic resonance first-pass perfusion
and late gadolinium enhancement im-
aging. J Cardiovasc Magn Reson
8:831–837
19. Gerber BL, Garot J, Bluemke DA, Wu
KC, Lima JA (2002) Accuracy of
contrast-enhanced magnetic resonance
imaging in predicting improvement of
regional myocardial function in patients
after acute myocardial infarction.
Circulation 106:1083–1089
20. Kramer CM, Rogers WJ Jr., Mankad S,
Theobald TM, Pakstis DL, Hu YL
(2000) Contractile reserve and contrast
uptake pattern by magnetic resonance
imaging and functional recovery after
reperfused myocardial infarction. J Am
Coll Cardiol 36:1835–1840
21. Raff GL, O’Neill WW, Gentry RE et al
(2006) Microvascular obstruction and
myocardial function after acute myo-
cardial infarction: assessment by using
contrast-enhanced cine MR imaging.
Radiology 240:529–536
22. Stork A, Lund GK, Muellerleile K et al
(2006) Characterization of the peri-
infarction zone using T2-weighted MRI
and delayed-enhancement MRI in pa-
tients with acute myocardial infarction.
Eur Radiol 16:2350–2357
23. Judd RM, Lugo-Olivieri CH, Arai M et
al (1995) Physiological basis of myo-
cardial contrast enhancement in fast
magnetic resonance images of 2-day-
old reperfused canine infarcts. Circula-
tion 92:1902–1910
24. Bogaert J, Kalantzi M, Rademakers FE,
Dymarkowski S, Janssens S (2007)
Determinants and impact of microvas-
cular obstruction in successfully reper-
fused ST-segment elevation myocardial
infarction. Assessment by magnetic
resonance imaging. Eur Radiol
17:2572–2580
25. Ambrosio G, Weisman HF, Mannisi
JA, Becker LC (1989) Progressive
impairment of regional myocardial
perfusion after initial restoration of
postischemic blood flow. Circulation
80:1846–1861
26. Kloner RA, Ganote CE, Jennings RB
(1974) The “no-reflow” phenomenon
after temporary coronary occlusion in
the dog. J Clin Invest 54:1496–1508
2912